Sector ratings Laboratorios Farmaceuticos Rovi, S.A.

Stocks

Real-time Estimate Tradegate 08:45:55 2026-08-18 am EDT			5-day change	1st Jan Change
57.75 ^EUR	+0.26%		-1.20%	-9.21%

Jul. 23	Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026
Jul. 23	Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
LABORATORIOS FARMACEUTICOS ROVI, S.A.	3.41B		BBB
ELI LILLY AND COMPANY	1,055B		A
JOHNSON & JOHNSON	632B	-	BBB	-	-
ABBVIE INC.	442B		AA		-
ROCHE HOLDING AG	351B		AA
NOVARTIS AG	290B		AAA
ASTRAZENECA PLC	243B		A
AMGEN INC.	227B		A
NOVO NORDISK A/S	200B		A
GILEAD SCIENCES, INC.	172B		AA
PFIZER INC.	153B		A
BRISTOL-MYERS SQUIBB COMPANY	132B		A
VERTEX PHARMACEUTICALS INCORPORATED	131B		AA
SANOFI	106B		AA
GSK PLC	101B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	70.87B		AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	55.24B		AA
BAYER AG	54.51B		AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	51.66B		AA
TEVA PHARMACEUTICAL INDUSTRIES LIMITED	42.49B		-
Average	225.67B		AA
Weighted average by Cap.			AA